OpenAlex
PricingAboutJobs
Log inGet started
Work

Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure

HTML

Year: 2019
Type: review
Source: Metabolism
DOI: 10.1016/j.metabol.2019.154045
Authors: Francesco Giorgino, Irene Caruso, Julia Moellmann, Michael Lehrke
Institutions: University of Bari Aldo Moro, Universitätsklinikum Aachen
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, GLP-1 receptor agonists, atherosclerotic heart disease, congestive heart failure, diabetes mellitus, cardiovascular mortality, renal outcomes, patient selection, drug safety
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, LifeScan, Boehringer Ingelheim, Deutsche Forschungsgemeinschaft, Novo Nordisk, Takeda Medical Research Foundation, Merck Sharp and Dohme
Award: G408933901
OpenAlex ID: W2992147736
FWCI: 0.776
Cites: 129
Cited by: 26
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security